Indapamide Biogaran (Indapamide Hemihydrate)

Indapamide inhibits the sodium‑chloride symporter in the distal convoluted tubule of the kidney, decreasing Na⁺/Cl⁻ reabsorption. This leads to increased urinary excretion of sodium and water, which reduces plasma volume and peripheral vascular resistance, resulting in lowered blood pressure and decreased fluid accumulation.

The appropriate dose of Indapamide Biogaran is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Dosage adjustments are made according to clinical guidelines and patient monitoring; patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety data for Indapamide during pregnancy and lactation are limited, and the drug is generally avoided unless the potential benefit outweighs the risk. Healthcare providers should evaluate the risk‑benefit profile for each patient, and alternative therapies may be considered for pregnant or nursing women.

To request Indapamide Biogaran, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with conventional thiazide diuretics, Indapamide offers a longer duration of action and a lower incidence of metabolic disturbances such as hypokalemia. It is often used when additional diuretic potency is needed or when patients experience side effects with other agents, but the choice of therapy depends on individual patient factors and clinician judgment.

Indapamide Biogaran tablets should be stored at temperatures below 25 °C, in their original packaging, protected from moisture and direct sunlight. Keeping the product in a dry, controlled environment helps maintain its stability and potency throughout its shelf life.

Indapamide Biogaran is taken orally, usually once daily in the morning with or without food, as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed. Consistent timing helps maintain stable blood pressure control.

The most serious risks include severe electrolyte disturbances such as hyponatremia or hypokalemia, dehydration, acute kidney injury, and rare allergic reactions like Stevens‑Johnson syndrome. Patients should be monitored regularly for signs of these conditions, and any concerning symptoms should prompt immediate medical evaluation.

Indapamide Biogaran is contraindicated in patients with known hypersensitivity to indapamide or other sulfonamide‑derived drugs, and should be used with caution in individuals with severe renal or hepatic impairment, uncontrolled diabetes, or those taking interacting medications such as lithium. Clinicians must assess each patient’s medical history before initiating therapy.